Psoriatic Arthritis — Trials, FDA Actions & Pivotal Research
8 updates aggregated from openFDA and ClinicalTrials.gov, covering trial milestones, FDA actions, and pivotal publications about Psoriatic Arthritis.
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
Drugs with Psoriatic Arthritis trials
Recruiting trials by city
Cities where Psoriatic Arthritis trials in our archive had recruiting sites. Each link lists every currently recruiting paid clinical trial at that location.
Updates
2026
- Primary completionBimekizumab Phase 3 Trial for Psoriatic Arthritis Reaches Primary Completion· Feb 6, 2026· drug: Bimekizumab
2025
- Results postedAdalimumab Early TNF Inhibition Improves Psoriatic Arthritis Disease Activity· Nov 26, 2025· drug: Adalimumab
- Primary completionIxekizumab + Tirzepatide Phase 3 Trial for Psoriatic Arthritis & Obesity…· Nov 18, 2025· drug: Ixekizumab
- Results postedDeucravacitinib Shows Superior ACR 20 Response in Psoriatic Arthritis· Oct 24, 2025· drug: Deucravacitinib
- Results postedSecukinumab Shows Improved Psoriatic Arthritis HAQ-DI Response vs. Ustekinumab· Oct 16, 2025· drug: Secukinumab
- Results postedPsoriatic Arthritis: Tofacitinib Achieves Up to 47.4% Low Disease Activity· Oct 14, 2025
- Results postedIxekizumab Hits 86% PASI-75 in Plaque Psoriasis, 84% ACR20 in Psoriatic…· Aug 22, 2025· drug: Ixekizumab
- Results postedCrohn's Disease: UK Study Posts VTE, PE, DVT Risk Data· Jun 11, 2025